TEAM - KLEEM CHAUDHARY

Dr. Chaudhary joined Hyku Biosciences in 2024. He brings diverse and successful leadership experiences from his previous roles at multiple pharma and biotech companies. Most recently, he was Chief Operating and Business Officer at Redona Therapeutics, a company targeting dysregulated RNA and DNA processes in serious diseases. Prior to Redona, he was Chief Business Officer at Checkmate Pharmaceuticals, an immuno-oncology company where he was instrumental in its Series C financing, IPO and led the subsequent sale of the company to Regeneron. Previously, he held business development roles of increasing responsibility at Novartis, Takeda, and Biogen. Dr. Chaudhary started his industry career as a medicinal chemist at Gilead Sciences. He holds a Ph.D. in chemistry from the University of North Carolina at Chapel Hill and a B.Sc. in chemistry from the University of Winnipeg.